Spine and spinal cord disorder Spine and Spinal Cord Disease Patients, neurological disorde
Conditions
Interventions
To compare the effectiveness and safety of biomagnetic field testing as a diagnostic aid in the evaluation of neurological disorders in patients with spine and spinal cord disorder by comparing existi
Biomagnetic field testing
Sponsors
kawabata Shigenori
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients who are at least 18 years old at the time of consent 2. Patients who have been diagnosed with neurological disorders of the spinal cord or spinal nerve by screening with existing tests. ( Diagnosis is made by doctors with at least 10 years of experience in the treatment of spinal diseases.) 3. Patients who are able to obtain written consent in person.
Exclusion criteria
Exclusion criteria: 1. patients whose diagnosis is unknown or whose diagnosis is other than spine or spinal cord disease on existing examinations (Patients who are evaluated as [Group 3] by the Case Evaluation Committee.) 2. patients who cannot undergo MRI 3. patients who inhaled or swallowed magnetic powder 4. patients with severe peripheral neuropathy 5. patients requiring 24-hour ventilator management 6. Diabetic patients with poor glycemic control 7. patients with a history of serious heart disease (ischemic heart disease, arrhythmia, heart failure, etc.) 8. patients with implanted cardiac pacemakers, implantable cardioverter defibrillators, other magnetic metal devices or electronic devices. 9. patients with epilepsy or psychiatric disorders 10. patients with a history of treatment of cerebral aneurysms with intraoperative devices such as vascular clips or vascular shunts or catheters with electronic devices 11. patients with cervical spinal cord neuropathy from C1 to C2 12. patients with C3 cervical spinal cord neuropathy requiring respiratory management. 13. patients with skin diseases and skin infections at the site of electrode placement of the electromyograph. 14. patients who have difficulty with adequate electrical stimulation (e.g., patients with thick subcutaneous fat in the stimulation area, patients who are hypersensitive to electrical stimulation, etc.) 15. patients with potentially life-threatening diseases 16. patients with alcohol or drug intoxication 17. patients who have been administered convulsant-inducing drugs or anesthesia 18. patients with dementia or impaired level of consciousness who are unable to give consent. 19. patients with spinal kyphosis and poor fitting of the measurement plane (severe sagittal spine deformity, obesity, etc.) 20. pregnant women, women who wish to become pregnant during the study period, or lactating women 21. patients who have participated in other research studies within one year prior to the use of the research device 22. Also , patients who are deemed inappropriate for inclusion in this study by the general manager or a physician who is a research associate.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Number of surgical patients duration of an illness | — |
Contacts
Public ContactShigenori kawabata
Tokyo Medical and Dental univ
Outcome results
None listed